The drug is the novel injectable approved for addressing diabetes type 2 and excess body fat in patients. This treatment works by copying the actions of natural hormones, in essence GIP and GLP-1, to improve sugar levels and promote satiety which weight reduction. Expected benefits feature significant progress in A1C levels, decreased likelihood of